MAPT and Alzheimer disease: The upsurge in circulating IL-18 levels may signify a state of chronic inflammation within the brain, and its overexpression could potentially trigger tau protein phosphorylation, consequently contributing to neurodegeneration in Alzheimer's Disease (AD) patients (18).